ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,650.00
-25.00 (-0.93%)
At close: Apr 28, 2026

ADBiotech Revenue

In the year 2025, ADBiotech had annual revenue of 12.90B KRW with 15.81% growth. ADBiotech had revenue of 2.97B in the quarter ending December 31, 2025, a decrease of -36.01%.

Revenue
12.90B
Revenue Growth
+15.81%
P/S Ratio
4.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202512.90B1.76B15.81%
Dec 31, 202411.14B664.30M6.34%
Dec 31, 202310.47B-159.63M-1.50%
Dec 31, 202210.63B-1.21B-10.21%
Dec 31, 202111.84B2.02B20.63%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
J2KBIO 32.97B
Parataxis Korea 9.00M
EyeGene 3.57B
Poongjeon Pharmacy CO.,LTD. 1.54B
HLB Pep 4.96B
Aptamer Sciences 1.08B
Ark Solutions 16.08B
Psomagen 59.19B
Revenue Rankings